The aryl hydrocarbon receptor (AHR) mediates the toxic effects of dioxin (2, 3, 7, TCDD), which includes thymic atrophy, steatohepatitis, and a lethal wasting syndrome in laboratory rodents. Although the mechanisms of dioxin toxicity remain unknown, AHR signaling in hepatocytes is necessary for dioxin-induced liver toxicity. We previously reported that loss of TCDD-inducible poly(adenosine diphosphate [ADP]-ribose) polymerase (TIPARP/PARP7/ARTD14), an AHR target gene and mono-ADP-ribosyltransferase, increases the sensitivity of mice to dioxin-induced toxicities. To test the hypothesis that TIPARP is a negative regulator of AHR signaling in hepatocytes, we generated Tiparp fl/fl mice in which exon 3 of Tiparp is flanked by loxP sites, followed by Cre-lox technology to create hepatocyte-specific (Tiparp together, these data illustrate that TIPARP is an important negative regulator of AHR activity, and that its specific loss in hepatocytes is sufficient to increase sensitivity to dioxin-induced steatohepatitis and lethality.
helix-loop-helix Period-AHR nuclear translocator (ARNT)-Single-minded family of transcription factors. In the canonical AHR signaling pathway, ligand binding to cytosolic AHR causes its translocation to the nucleus where it dimerizes with ARNT (also known as hypoxia-inducible factor 1b). The AHR: ARNT heterodimer then binds DNA sequence elements (termed AHREs or DREs) located within the regulatory regions of its target genes, which include cytochrome P4501A1 (CYP1A1), CYP1B1, and TCDD-inducible adenosine diphosphate (ADP)-ribose polymerase (TIPARP) (Ma et al., 2001; Whitlock, 1999; Zhang et al., 1998) . In addition to its roles in dioxin toxicity, xenobiotic metabolism and vascular development (Stevens et al., 2009) , AHR has important roles in T-cell differentiation, in the defense against bacterial infections and in gut homeostasis (MouraAlves et al., 2014; Quintana et al., 2008) . To date, >400 AHR ligands have been identified, including dietary compounds (3, 3'-diindolylmethane), various endogenous ligands (kynurenine, 6-formylindolo(3, 2b) carbazole), and environmental contaminants such as dioxin (Denison and Nagy, 2003) .
Dioxin causes diverse toxic effects in laboratory rodents including immunosuppression, steatohepatitis, impaired reproduction, and a lethal wasting syndrome (Birnbaum, 1994 (Birnbaum, , 1995 Poland and Knutson, 1982) . A single dose of dioxin induces a lethal starvation-like syndrome, which includes decreased gluconeogenesis, liver damage, steatohepatitis and dyslipidaemia, ultimately leading to lethality (Linden et al., 2010; Seefeld et al., 1984) . Acute lethality varies widely both among species and between rodent strains. For example, the median lethal dose (LD 50 ) for guinea pigs is 1-2 lg/kg dioxin, whereas the LD 50 for hamsters is >5000 lg/kg (Pohjanvirta and Tuomisto, 1994; Poland and Knutson, 1982) . In most strains of mice, lethality occurs only 2-3 weeks after a single dose of 115-300 lg/kg of dioxin (Pohjanvirta and Tuomisto, 1994; Poland and Knutson, 1982) . There is a roughly 10-fold difference in susceptibility between the high sensitivity C57BL/6 (Ahr b1 allele) and low sensitivity DBA/2 (Ahr d allele) mouse strains, which is due to polymorphic variations in their ligand-binding domains (Poland et al., 1994) . The molecular mechanisms of dioxin-induced wasting syndrome remain obscure, but transgenic mice overexpressing AHR show increased sensitivity to dioxin toxicities, whereas Ahr À/À null and Ahr dbd mice, which express a mutant AHR that does not bind to AHREs, are resistant to the effects of dioxin (Fernandez-Salguero et al., 1996; Lee et al., 2010; Walisser et al., 2005) . TIPARP (PARP7/ARTD14) is an AHR-regulated gene and a member of the poly-adenosine diphosphate (ADP)-ribose polymerase (PARP) family. PARPs are nicotinamide adenine dinucleotide (NAD þ )-dependent enzymes that use NAD þ as a substrate
to transfer 1 molecule of ADP-ribose, referred to as mono-ADPribosylation (MARylation), or several ADP-ribose moieties, referred to as poly-ADP-ribosylation (PARylation), to specific amino acid residues on themselves and on target proteins (Hottiger et al., 2010) . Mono-and poly-ADP-ribosylation are reversible posttranslational modifications involved in several biological processes, such as immune cell function, regulation of transcription, protein expression and DNA repair (Kraus and Hottiger, 2013) . We previously reported that TIPARP is a mono-ADP-ribosyltransferase that functions as part of a negative feedback loop to repress AHR activity through a mechanism that involves reduced ligand-induced AHR protein levels and that requires TIPARP's catalytic activity (MacPherson et al., 2013) . Moreover, Tiparp À/À mice exhibit increased AHR activity but also increased sensitivity to dioxin-induced toxicities, including steatohepatitis, hepatotoxicity and lethal wasting syndrome (Ahmed et al., 2015) . Although the mechanisms of dioxininduced toxicity remain incompletely understood, AHR expression in hepatocytes is needed to generate the adaptive as well as toxic response to dioxin exposure (Walisser et al., 2005 ); only ES clone G3 resulted in successful germline transmission. Some Tiparp þ/tm1a mice were bred to B6.C-Tg(CMV-cre)1Cgn/J (Jackson Labs, Bar Harbor, Maine) to remove the Neo cassette and the targeted exon and leave the lacZ reporter gene (conversion to tm1b allele) and then outbred once to C57BL/6N to remove Tg-(CMV-cre). Mice heterozygous for the tm1b allele were then intercrossed to make homozygous tm1b mice (Tiparp
, referred to as Tiparp Ex3À/À ). Other Tiparp þ/tm1a mice were bred to B6(C3)-Tg(Pgk1-FLPo)10Sykr/J (Jackson Labs) to remove the lacZ and Neo cassettes and leave the targeted exon flanked by LoxP sites (conversion to tm1c allele) and then outbred once to C57BL/6N to remove Tg-(Pgk1-FLPo) (Tiparp
). Tiparp þ/tm1c mice were bred to B6.C-Tg(CMV-cre)1Cgn/J to remove the targeted exon (conversion to tm1d allele) and then outbred once to C57BL/6N to remove Tg-(CMV-cre). Mice heterozygous for the tm1d allele were then intercrossed to make homozygous tm1d mice (Tiparp . Both tm1b and tm1d lines were used.
In vivo dioxin treatment studies. All experiments used 8-to 10-week-old male mice. For the acute 6 h exposure studies, Tiparp Ex3À/À or Tiparp fl/fl Cre Alb mice and their respective strainspecific WT control mice were treated with a single intraperitoneal (i.p.) injection of 100 lg/kg dioxin, and livers were excised and flash frozen 6 h later. For the subacute dioxin toxicity studies, mice were treated with a single i.p. injection of 10 or 100 lg/ kg of dioxin and sacrificed on day 6. The 10 lg/kg dose of dioxin was dissolved in a mixture of corn oil and dimethyl sulfoxide (CO:DMSO; 90:10, referred to as CO), while the 100 lg/kg dose of dioxin was dissolved in pure DMSO. For the survival studies, mice were followed for up to 30 days after a single injection of 10 or 100 lg/kg of dioxin. Control mice received equivalent weight-adjusted volumes of CO or DMSO. The time point for euthanization was determined based on endpoint criteria for our study: a loss of 20% body weight or indications of acute distress. All control mice were euthanized to match the endpoints of dioxin-sensitive mice. For food intake studies, mice were housed individually and provided intact pellets of food that were weighed daily; a baseline was determined for each mouse by monitoring for 1 week prior to treatment as described previously (Ahmed et al., 2015) . Whole blood was obtained from the saphenous vein for serum alanine aminotransferase (ALT) analysis as described previously in Ahmed et al. (2015) . Hepatic glycogen levels were determined from 10 mg of frozen liver using the Glycogen Assay Kit II (Abcam Cre Alb mice treated with vehicle, 10 or 100 mg/kg dioxin were collected either on day 6 or on the day of euthanization in the survival studies. Care and treatment of animals followed the guidelines set by the Canadian Council on Animal Care, and all protocols were approved by the University of Toronto Animal Care Committee.
Hepatocytes. Tiparp fl/fl
Cre Alb or Tiparp fl/fl male mice (8-to 10-weeks old) were used to isolate primary hepatocytes. Mouse liver was perfused with liver perfusion medium (Invitrogen) for 10 min followed by liver digestion medium for 10 min. Freshly prepared hepatocytes were seeded at a final density of 0.5 Â 10 6 cells/well onto type I collagen coated 6-well plates in attachment medium (William's E media, 10% dextran-coated charcoal (DCC) stripped fetal bovine serum (FBS), 1Â penicillin/ streptomycin, and 10-nM insulin). The medium was changed 2 h after plating, and all experiments were performed on the second day. Ligands were added to the cells in M199 media with 5% DCC-FBS and cells were harvested 16 h after ligand treatment for RNA extraction.
RNA extraction and gene expression analysis. Livers were removed, washed in ice-cold PBS, weighed, and flash frozen in liquid nitrogen. Frozen livers were homogenized in TRIZOL reagent (Life Technologies) and total RNA was isolated using the Aurum RNA isolation kits (BioRad) and reverse transcribed as previously described (Ahmed et al., 2015) . Primers used to amplify target transcripts are provided in Supplementary Table 1 or described elsewhere (Ahmed et al., 2015) . All genes were normalized to TATA-binding protein levels and analyzed using the comparative C T (DD C T ) method.
Chromatin immunoprecipitation (ChIP) assays. ChIP assays were performed as previously described in Lo et al. (2011 Western blotting. For hepatic AHR protein detection, whole cell extracts were prepared by homogenizing 100 mg of liver tissue in RIPA lysis buffer. Ten micrograms of total protein were separated by SDS-PAGE and transferred to a nitrocellulose membrane. Membranes were incubated with antiAHR antibody (SA-210) and stripped and then incubated with antib-actin antibody (Sigma A-2228).
Metabolomics. Tiparp fl/fl and Tiparp fl/fl Cre Alb mice were treated with a single intraperitoneal injection of CO: DMSO or 10 lg/kg dioxin. Liver tissue (100 mg) was collected on day 3 and flash frozen in liquid nitrogen. The frozen tissue was extracted and metabolomic analyses were performed by Metabolon (Durham, North Carolina). Raw data received from Metabolon were preprocessed to input missing values and normalized using logarithmic transformation. Shapiro's test was used to test for normality and Levene's test was used to test for the homogeneity of variances. Analysis of variance (ANOVA) was used to analyze the differences in group means, followed by Tukey's-HSD for post hoc correction. The FDR method was used to adjust the p-values for multiple ANOVA tests (one for each metabolite). At an FDR of 10%, all the group comparisons that exhibited a statistically significant difference (post hoc corrected p-values < .05) were considered significant. All the analyses were performed in R version 3.4.1.
Statistical analysis. All data were presented as means and SEM. Two-way ANOVA followed by Sidak's post hoc test or 1-way ANOVA followed by Tukey's post hoc test were used to assess statistical significance (p < .05) using GraphPad Prism 6 Software (San Diego, California) or R version 3.4.1.
RESULTS

Generation of Conditional Tiparp fl/fl Mice
Mice harboring the conditional Tiparp fl allele were generated from Tiparp tm1a(EUCOMM)Wtsi ES cells purchased from EUCOMM. A partial map of both the Tiparp WT and Tiparp tm1a alleles is shown in Figure 1A . Southern blotting of genomic DNA isolated from 4 different ES cell clones confirmed the correct integration of the tm1a allele in the ES cell clones D3 and G3 ( Figure 1B ).
Mice generated in this study were from ES cell clone G3. Mice harboring the conditional Tiparp fl allele were generated from the Tiparp tm1a allele by excision of the Neo and LacZ genes through crosses with B6(C3)-Tg(Pgk1-FLPo)10Sykr/J mice, leaving the targeted exon flanked by LoxP sites. Mice heterozygous for the tm1c allele were then intercrossed to make homozygous tm1c mice (Tiparp fl/fl ; tm1c allele).
Complete and Hepatocyte-Specific Excision of the Tiparp fl/fl Allele
Using genetrap targeted TIPARP null mice in which a LacZ gene is inserted in front of exon 1 in the Tiparp gene (Schmahl et al., 2007) , we reported that loss of TIPARP expression increased the sensitivity of mice to dioxin-induced steatohepatitis and lethality (Ahmed et al., 2015) . These findings supported the notion that TIPARP protects against dioxin-induced toxicity by negatively regulating AHR action. Because the type of gene knockout targeting strategy can impact the phenotypes observed from targeting the same gene, we created a complete TIPARP knockout by removal of exon 3 of Tiparp (Tiparp Ex3À/À ) as described in Materials and Methods section. To generate a complete TIPARP null mouse in which exon 3 is removed (Tiparp Ex3À/À ) we used 2 different strategies. In the first approach, mice heterozygous for the tm1c allele were bred to B6.C-Tg(CMV-cre)1Cgn/J mice to remove the targeted exon (Tiparp Ex3À/À ; tm1d allele). In second approach, mice carrying the tm1a allele were bred to B6.C-Tg(CMV-cre)1Cgn/J mice to remove the Neo cassette and the targeted exon and leave the lacZ reporter (Tiparp Ex3À/À ; tm1b allele). A map of the Tiparp tm1c, tm1d, and tm1b alleles is shown in Figure 1C . The correct genotype was confirmed by PCR analysis of genomic DNA ( Figure 1D ). Tiparp Ex32/2 mice represent a distinct TIPARP null strain compared with Tiparp targeted knockout using a genetrap approach (Ahmed et al., 2015; Schmahl et al., 2007) . To determine whether the loss of TIPARP in hepatocytes is sufficient to increase sensitivity to dioxindependent toxicity, we generated mice in which Tiparp was deleted in hepatocytes, Tiparp The Tiparp tm1a allele was converted to tm1b using CRE recombinase to remove the Neo cassette and exon 3 located between the LoxP sites. Primer pair D-E amplify a product spanning the excision sites to show that the floxed sequences were removed (420 bp). The Tiparp tm1a allele was converted to tm1c using FLP recombinase to remove the LacZ and Neo cassettes located between the FRT sites. Primer pair A-B amplifies a product spanning the excision site to show that the sequence was flipped out (750 bp). The Tiparp tm1c allele was converted to tm1d using CRE recombinase to remove the floxed exon 3. Primer pair A-E amplify a product spanning the floxed region to show that the exon is removed (310 bp). Sample genotypes: þ indicates the Tiparp WT allele; letters indicate the Tiparp tm1 corresponding allele (tm1a, tm1b, tm1c, and tm1d).
only the Tiparp fl -unexcised allele in all tissues and isolated hepatocytes examined (Figure 2A ).
Cloning and DNA sequencing revealed that the conditional inactivation of the Tiparp fl allele accomplished by Cre-mediated deletion of exon 3 (169 bp) results in splicing and fusion between exon 2 (961 bp) and exon 4 (161 bp), leading to the insertion of a premature stop codon. This truncated version of TIPARP contains 311 amino acids, of which the last 4 are the result of a frameshift (the full-length protein is 657 a.a.), and it lacks its tryptophan-tryptophan-glutamate (WWE) and catalytic domains (MacPherson et al., 2013) . In agreement with a previous study, cloning and transient transfection of the truncated TIPARP protein failed to inhibit AHR-dependent and dioxin-induced 
Toxicity and Lethality
To determine the sensitivity of Tiparp Ex3À/À mice to dioxininduced toxicity, these mice and their respective WT controls were injected with a single dose of 10 or 100 lg/kg dioxin and monitored for up to 30 days, as previously described (Ahmed et al., 2015) . All Tiparp Ex3þ/þ mice were normal in physical appearance at the end of the 30-day observation period (Figure 4A ), while no dioxin-treated Tiparp Ex3À/À mice (tm1d or tm1b) survived the 30-day experiment ( Figure 4A ). Tiparp Ex32/2 mice treated with 100 lg/kg dioxin became weakened and moribund and were humanely euthanized between days 2 and 3, while those treated with 10 lg/kg dioxin were euthanized at day 7. Tiparp Ex3À/À mice treated with 10 lg/kg dioxin had lost significant body weight by 5 days after treatment ( Figure 4B) ; however, no decrease in food intake was observed ( Figure 4C ). No changes in food intake or body weight were seen in dioxin-exposed Tiparp þ/þ mice. Serum ALT activity, a marker of hepatotoxicity, was significantly increased in dioxin-treated Tiparp Ex3À/À mice, while no increase above controls was observed in Tiparp þ/þ mice ( Figure 4D ). Increased liver weight was observed in dioxintreated Tiparp þ/þ mice but not in Tiparp Ex3À/À mice ( Figure 4E ).
Thymic involution, an endpoint associated with dioxin toxicity, responded as expected in both genotypes at day 7 ( Figure 4F) . A significant decrease in epididymal WAT weight was seen in Tiparp Ex3À/À mice but not in WT mice ( Figure 4G ). No differences in BAT weight were observed (data not shown). Hepatic glycogen stores were lower in dioxin-treated Tiparp Ex3À/À mice than in WT mice ( Figure 4H ). These data support the importance of TIPARP in regulating AHR action and show that loss of its expression in mice increases their sensitivity to dioxin toxicity.
Hepatocyte-Specific Loss of TIPARP Results in Increased Sensitivity to Dioxin-Induced Toxicity and Lethality Because AHR expression in hepatocytes is required for dioxininduced liver toxicity, we hypothesized that the loss of TIPARP expression in hepatocytes would enhance dioxin-dependent Cre Alb mice treated with 100 lg/kg dioxin appeared weakened and moribund and were humanely euthanized between days 3 and 5, while those treated with 10 lg/kg dioxin were humanely euthanized at day 9. Sensitivity to dioxin-induced lethality was significantly different between Tiparp fl/fl Cre Alb and Tiparp Ex3À/À mice at both 10 and 100 lg/kg dioxin, suggesting that cells other than hepatocytes also contribute to dioxin lethality in these models. Tiparp fl/fl Cre Alb mice treated with 10 lg/kg dioxin had lost significant body weight by 6 days after treatment ( Figure 5B ), while no decrease in food intake was observed ( Figure 5C ). No change in food intake or body weight was seen in Tiparp fl/fl mice. Serum ALT was significantly increased in dioxin-treated Tiparp fl/fl Cre Alb mice at days 3 and 6, but no increase was observed in Tiparp fl/fl mice ( Figure 5D ). Figure 5H ). These findings show that hepatocyte-specific deletion of TIPARP is sufficient to increase dioxin-induced toxicity and lethality.
Increased liver weight was observed in dioxin-treated
As an independent measure of liver toxicity, livers were sectioned and stained with hematoxylin and eosin. Vehicle-treated Figure 2A) . We next determined the mRNA levels of AHR-regulated cytokines and the macrophage marker F4/80 (Casado et al., 2011; Matsubara et al., 2012) . Hepatic interleukin 6 (Il6) levels were unaffected by dioxin treatment in both genotypes ( Figure 6B We then analyzed the hepatic levels of transcripts encoding genes involved in lipid uptake, lipogenesis and cholesterol/bile acid metabolism. Consistent with previous studies (Lee et al., 2010; Lu et al., 2011) , the lipid uptake transporter, scavenger receptor encoded by cluster of differentiation 36 (Cd36), was in- 
Serpine 1 (H) were determined after 3 days of exposure to CO or 10 lg/kg dioxin as described in experimental procedures (n ¼ 4). Recruitment of AHR to Cyp1a1 (I) and Cyp1b1 (J). Data represent the mean 6 SEM. Representative AHR (K), and b-actin protein levels were detected by Western blotting after 3 days of treatment. AHR proteins levels were normalized to b-actin levels, n ¼ 4) (L). For all data, p < .05 was determined by 2-way ANOVA fol- Table 4) . Consistent with previous studies, dioxin treatment resulted in significant lipidomic changes, with accumulation of several classes of free fatty acids and metabolites linked to complex lipid homeostasis (Nault et al., 2016b Cre Alb mice also differed with regard to increased cglutamyl-e-lysine levels (12.5-fold; Figure 9E ), which may reflect increased transglutaminase activity, and polyamine metabolism (N-acetylputrescine; Figure 9F , and putrescine; Figure 9G ). Because dioxin toxicity has been tightly linked with NAD þ levels, its precursors and metabolites, and because TIPARP activity is dependent on NAD þ , we examined NAD þ metabolism (Diani-Moore et al., 2010 , 2017 He et al., 2013) . Dioxin-dependent increases in nicotinamide ribonucleoside ( Figure 9H ) and nicotinamide ( Figure 9I 
DISCUSSION
We previously reported that TIPARP acts as part of negative feedback loop to regulate AHR activity, and that global loss of TIPARP expression increases sensitivity to dioxin-induced toxicities such as steatohepatitis and wasting syndrome (Ahmed et al., 2015; MacPherson et al., 2013) . Since hepatocyte-specific deletion of AHR prevents dioxin-induced hepatotoxicity, we reasoned that hepatocyte-specific deletion of TIPARP would result in increased dioxin-induced hepatotoxicity. We therefore generated a hepatocyte-specific TIPARP deletion (Tiparp fl/fl Cre Alb ) mouse strain. We also generated a whole-body knockout TIPARP (Tiparp Ex3À/À ) strain in which Tiparp is deleted by the removal of exon 3, making it distinct from other TIPARP null lines (Ahmed et al., 2015; Kozaki et al., 2017; Schmahl et al., 2007 Cre Alb mice are both more sensitive than WT mice to dioxin-induced hepatotoxicity and lethality. These findings provide further support for the importance of TIPARP in AHR signaling and for its role in protecting against dioxin-induced toxicity (Ahmed et al., 2015; Matthews, 2017) , as well as demonstrating that the expression of TIPARP in hepatocytes plays a key role in the manifestations of this toxicity. Tiparp fl/fl Cre Alb mice treated with dioxin lost significant body weight without any reduction in food intake. Hepatic glycogen and epididymal WAT levels were also reduced, pointing to a possible deficiency in the efficiency of intestinal nutrient absorption resulting in altered metabolism. Dioxin-induced hypophagia contributes to body weight and adipose tissue loss in many species, but numerous studies using pair-feeding or total parenteral nutrition have failed to identify a single explanation for the weight loss (Linden et al., 2010; Seefeld et al., 1984 (Duval et al., 2017) . Srebp1 expression is positively regulated by the liver X receptor (LXR) and PPARa. TIPARP is an LXR coactivator, so the loss of Tiparp expression combined with the reduced PPARa expression levels could also contribute to reduced SREBP1 levels (Bindesboll et al., 2016) . CYP7A1 plays a critical role in the control of bile acid and cholesterol homeostasis as the rate-limiting enzyme in the classic bile acid synthesis pathway (Gupta et al., 2001) . Overexpression of mouse CYP7A1 protects against high-fat diet induced obesity, fatty liver and insulin resistance , whereas in humans, genetic deficiency of CYP7A1 leads to hyperlipidemia (Pullinger et al., 2002) . The decrease in CYP7A1 expression levels in treated Tiparp fl/fl Cre Alb and Tiparp Ex3À/À mice is in agreement with studies of male C57BL/6 mice treated with 0.01 to 30 lg/kg dioxin every 4 for 28 days (Fader et al., 2017) , and could be a contributing factor to the increased hepatosteatosis and reduced WAT levels observed, through reduced lipid absorption resulting from altered bile acid homeostasis (Fader et al., 2017) . In support of this, we observed increased hepatic levels of taurochenodeoxycholic acid and taurocholic acid in dioxin-treated formed by tissue transglutaminase (TG2), which catalyzes crosslinks between glutamine and lysine residues of proteins (Iismaa et al., 2009) . TG2 activity increases following acute and chronic liver injury, and aberrant TG2 activation has been implicated in the development of fibrosis and cancer (Iismaa et al., 2009 ). In contrast, retinoid-induced TG2 mRNA up-regulation is reduced by dioxin treatment in a human squamous cell carcinoma cell line (Krig and Rice, 2000 (macrophage inflammation protein-2) and Serpine1 genes (Son and Rozman, 2002) . CXCL2 is a member of the CXC subfamily of chemokines that are crucial for neutrophil recruitment to sites of inflammation following hepatic injury (Marra and Tacke, 2014) . Levels of PAI-1, the product of Serpine1 gene, were higher in Tiparp fl/fl Cre Alb mice than in Tiparp fl/fl mice. PAI-1 is a physiologic inhibitor of plasminogen activators that regulate fibrosis via regulation of the extracellular matrix. PAI-1 expression is increased in dioxin-induced fibrosis (Nault et al., 2016a) . The mRNA levels of AHR repressor (AHRR), a negative regulator of AHR (Mimura et al., 1999) , were increased in Tiparp fl/fl Cre Alb compared with Tiparp fl/fl mice. AHRR is a potent inhibitor of AHR activity in vitro (Karchner et al., 2009 ) that exhibits gene-and tissue-specific inhibition of AHR signaling in mice (Hosoya et al., 2008) . Although the effect of Ahrr loss on dioxin-induced wasting syndrome has not been reported, AHRR transgenic mice are protected from dioxin-induced lethality and hepatotoxicity (Vogel et al., 2016) . Increased TIPARP and PARP1 activity have been proposed to be important in augmenting dioxin toxicity through the depletion of NAD -consuming enzyme other than TIPARP is responsible for the reduced NAD þ levels after dioxin treatment in mice. Another possible explanation is that there are species differences in the AHR-TIPARP signaling axis, such that TIPARP protects against dioxin toxicity in mice but enhances it in avian species. Further studies using gene targeting methods to delete TIPARP in nonmurine models are needed to explain these discrepancies. AHR is also a key regulator of gut homeostasis, inflammation, immunity and T-cell differentiation (Stockinger et al., 2014) . AHR is required for the maintenance of intraepithelial lymphocytes, which are the first line of immune defense in the intestine. Loss of AHR or reduced exposure to dietary AHR ligands compromises these cells, leading to increased microbial load, immune activation and epithelial damage (Li et al., 2011) . Moreover, AHR activation by dietary indoles (indole-3-carbinol) improves colitis and protects against experimental autoimmune encephalomyelitis, a murine model of multiple sclerosis (Lamas et al., 2016; Li et al., 2011; Monteleone et al., 2011; Rouse et al., 2013) . An unanswered question is whether TIPARP also regulates endogenous AHR signaling and if so, how would its loss affect the protective role of the AHR signaling pathway in models of inflammatory disease? Kynurenine, an endogenous AHR ligand, was reported to repress type-I interferon responses during viral infection in an AHR-and TIPARP-dependent manner, supporting the notion that TIPARP has a broad role in AHR biology and regulates endogenous ligand-induced AHR activation (Yamada et al., 2016) .
In summary, we provide evidence from 2 additional mouse models that the loss of TIPARP expression increases sensitivity to dioxin toxicity and lethality. Hepatocyte-specific loss of TIPARP is sufficient to increase sensitivity to dioxin hepatotoxicity, steatosis and lethality, highlighting the importance of liver damage in the dioxin-induced wasting syndrome. Our results provide further support for the importance of the AHR-TIPARP axis in regulating dioxin toxicity, and potentially in regulating the biological actions of AHR following its activation by endogenous or dietary ligands.
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